$VRT
Vertiv Holdings Co

2019 Q3 Form 10-Q Financial Statement

#000119312519284707 Filed on November 05, 2019

View on sec.gov

Income Statement

Concept 2019 Q3 2018 Q4 2018 Q3
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue $719.4M
YoY Change
Gross Profit -$719.4M
YoY Change
Gross Profit Margin
Selling, General & Admin $259.3M $700.0K $300.0K
YoY Change 86333.33%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $51.30M
YoY Change
% of Gross Profit
Operating Expenses $259.3M $600.0K $300.0K
YoY Change 86333.33%
Operating Profit -$978.7M
YoY Change
Interest Expense $77.70M $3.600M $3.200M
YoY Change 2328.13%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$17.30M $3.000M $2.904M
YoY Change -695.83%
Income Tax -$3.600M $600.0K $607.4K
% Of Pretax Income 20.0% 20.92%
Net Earnings -$13.70M $2.349M $2.296M
YoY Change -696.67% -184180.64%
Net Earnings / Revenue
Basic Earnings Per Share -$0.12
Diluted Earnings Per Share -$0.12 $26.65K $26.65K
COMMON SHARES
Basic Shares Outstanding 118.3M shares
Diluted Shares Outstanding 118.3M shares

Balance Sheet

Concept 2019 Q3 2018 Q4 2018 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $200.0K $800.0K $1.000M
YoY Change -80.0%
Cash & Equivalents $159.5M $215.1M $693.7M
Short-Term Investments
Other Short-Term Assets $400.0K $300.0K $400.0K
YoY Change 0.0%
Inventory
Prepaid Expenses $353.8K $341.4K $409.5K
Receivables $0.00 $0.00
Other Receivables $0.00 $0.00
Total Short-Term Assets $548.3K $1.177M $1.394M
YoY Change -60.68% 4607.87%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill $634.0M
YoY Change
Intangibles
YoY Change
Long-Term Investments $703.9M $694.9M $692.7M
YoY Change 1.62%
Other Assets $1.100M $1.300M $1.100M
YoY Change 0.0%
Total Long-Term Assets $705.0M $696.2M $693.8M
YoY Change 1.62%
TOTAL ASSETS
Total Short-Term Assets $548.3K $1.177M $1.394M
Total Long-Term Assets $705.0M $696.2M $693.8M
Total Assets $705.6M $697.3M $695.2M
YoY Change 1.5% 2789256.2%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.234M $644.2K $200.9K
YoY Change 514.35% 50386.52%
Accrued Expenses $0.00 $500.0K $500.0K
YoY Change -100.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.235M $1.278M $1.451M
YoY Change -14.95% 100019.75%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $24.20M $24.20M $24.20M
YoY Change 0.0%
Total Long-Term Liabilities $24.20M $24.20M $24.20M
YoY Change 0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.235M $1.278M $1.451M
Total Long-Term Liabilities $24.20M $24.20M $24.20M
Total Liabilities $25.38M $25.43M $25.60M
YoY Change -0.85% 1992652.98%
SHAREHOLDERS EQUITY
Retained Earnings $4.998M $4.726M $2.377M
YoY Change 110.25% -1651.08%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$696.2M -$540.3M $5.000M
YoY Change
Total Liabilities & Shareholders Equity $705.6M $697.3M $695.2M
YoY Change 1.5% 2789256.2%

Cashflow Statement

Concept 2019 Q3 2018 Q4 2018 Q3
OPERATING ACTIVITIES
Net Income -$13.70M $2.349M $2.296M
YoY Change -696.67% -184180.64%
Depreciation, Depletion And Amortization $51.30M
YoY Change
Cash From Operating Activities $23.50M -$2.800M $2.100M
YoY Change 1019.05%
INVESTING ACTIVITIES
Capital Expenditures -$9.800M
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 -$690.0M
YoY Change
Cash From Investing Activities -$9.800M -$690.0M
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 28.90M 0.000 -300.0K
YoY Change -9733.33%
NET CHANGE
Cash From Operating Activities 23.50M -2.800M 2.100M
Cash From Investing Activities -9.800M -690.0M
Cash From Financing Activities 28.90M 0.000 -300.0K
Net Change In Cash 42.60M -692.8M 1.800M
YoY Change 2266.67%
FREE CASH FLOW
Cash From Operating Activities $23.50M -$2.800M $2.100M
Capital Expenditures -$9.800M
Free Cash Flow $33.30M
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q3 us-gaap Assets
Assets
705562140
CY2018Q4 us-gaap Assets
Assets
697339051
CY2019Q3 us-gaap Cash
Cash
194528
CY2018Q4 us-gaap Cash
Cash
835544
CY2019Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
353813
CY2018Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
341424
CY2019Q3 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
703920190
CY2018Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
694883137
CY2018Q4 us-gaap Dividends Receivable
DividendsReceivable
1278946
CY2019Q3 us-gaap Assets Current
AssetsCurrent
548341
CY2018Q4 us-gaap Assets Current
AssetsCurrent
1176968
CY2019Q3 gsah Deferred Underwriting Commissions
DeferredUnderwritingCommissions
24150000
CY2018Q4 gsah Deferred Underwriting Commissions
DeferredUnderwritingCommissions
24150000
CY2018Q4 gsah Accrued Offering Costs Current
AccruedOfferingCostsCurrent
538881
CY2019Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
214
CY2018Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
94439
us-gaap Net Income Loss
NetIncomeLoss
2681879
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2019Q3 us-gaap Liabilities Current
LiabilitiesCurrent
1234504
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1277528
CY2019Q3 us-gaap Liabilities
Liabilities
25384504
CY2018Q4 us-gaap Liabilities
Liabilities
25427528
CY2019Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
12389
CY2019Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
705562140
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
697339051
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2018Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
271932
CY2019Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
4997984
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
4726054
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
5000001
CY2019Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2019Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
15800000
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2019Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2018Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q3 us-gaap Revenues
Revenues
0
CY2018Q3 us-gaap Revenues
Revenues
0
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
454068
us-gaap Revenues
Revenues
0
us-gaap Revenues
Revenues
0
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
700000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
23724
CY2019Q3 us-gaap Investment Income Dividend
InvestmentIncomeDividend
3539155
CY2018Q3 us-gaap Investment Income Dividend
InvestmentIncomeDividend
3155923
gsah Adjustments To Additional Paid In Capital Accretion In Redemption Amount
AdjustmentsToAdditionalPaidInCapitalAccretionInRedemptionAmount
38942949
us-gaap Investment Income Dividend
InvestmentIncomeDividend
11311397
us-gaap Investment Income Dividend
InvestmentIncomeDividend
3769609
CY2019Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
850575
CY2018Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
252407
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1733276
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
376095
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2688580
CY2018Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2903516
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
9578121
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3393514
CY2019Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1234290
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
644208
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
691545932
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
564601
CY2018Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
607423
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2012008
gsah Payment Of Underwriting Discounts
PaymentOfUnderwritingDiscounts
13800000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
711635
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
2123979
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
2296093
us-gaap Net Income Loss
NetIncomeLoss
7566113
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
5000001
gsah Adjustments To Additional Paid In Capital Accretion In Redemption Amount
AdjustmentsToAdditionalPaidInCapitalAccretionInRedemptionAmount
8475243
gsah Temporary Equity Issued During Period Value New Issues
TemporaryEquityIssuedDuringPeriodValueNewIssues
664562652
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
564601
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2012008
CY2019Q3 us-gaap Due To Affiliate Current And Noncurrent
DueToAffiliateCurrentAndNoncurrent
10000
CY2019Q3 us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
30000
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
409549
CY2018Q3 us-gaap Stockholders Equity
StockholdersEquity
5000002
gsah Temporary Equity Issued During Period Value New Issues
TemporaryEquityIssuedDuringPeriodValueNewIssues
209130
us-gaap Increase Decrease In Dividends Receivable
IncreaseDecreaseInDividendsReceivable
-185337
us-gaap Increase Decrease In Dividends Receivable
IncreaseDecreaseInDividendsReceivable
1072455
gsah Increase Decrease In Deferred Offering Costs
IncreaseDecreaseInDeferredOfferingCosts
538881
us-gaap Profit Loss
ProfitLoss
7566113
us-gaap Profit Loss
ProfitLoss
2681879
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
590082
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
199635
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-94225
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
711635
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
7696037
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2136145
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
8396037
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
693682077
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
695718681
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
704114718
CY2018Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
693682077
CY2018Q2 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
690000000
CY2018Q2 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
15800000
CY2018Q2 us-gaap Payments For Deposits
PaymentsForDeposits
690000000
CY2019Q3 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
1.00
gsah Percentage Of Public Shares Required To Repurchase If Business Combination Is Not Completed Within Specified Period
PercentageOfPublicSharesRequiredToRepurchaseIfBusinessCombinationIsNotCompletedWithinSpecifiedPeriod
1.00
CY2019Q3 us-gaap Assets Held In Trust
AssetsHeldInTrust
705013799
CY2019Q3 us-gaap Dividends Receivable
DividendsReceivable
1093609
gsah Minimum Percentage Of Fair Market Value Of Business Acquisition To Trust Account Balance
MinimumPercentageOfFairMarketValueOfBusinessAcquisitionToTrustAccountBalance
0.80
gsah Period From Closing Of Public Offering To Complete Business Combination
PeriodFromClosingOfPublicOfferingToCompleteBusinessCombination
P24M
us-gaap Cost Of Trust Assets Sold To Pay Expenses
CostOfTrustAssetsSoldToPayExpenses
100000
CY2019Q3 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2019Q3 gsah Minimum Net Tangible Assets
MinimumNetTangibleAssets
5000001
us-gaap Increase Decrease Due From Officers And Stockholders
IncreaseDecreaseDueFromOfficersAndStockholders
-25000
gsah Proceeds From Sponsor Commitment
ProceedsFromSponsorCommitment
700000
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
300000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
300000
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
690000000
us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
90000
us-gaap Common Stock Voting Rights
CommonStockVotingRights
one vote for each share of common stock
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
690000000
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
15800000
gsah Adjustments To Additional Paid In Capital Proceeds From Sponsor Commitment
AdjustmentsToAdditionalPaidInCapitalProceedsFromSponsorCommitment
700000
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%;"><div style="color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Concentration of Credit Risk </div></div></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. </div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%;"><div style="color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Use of Estimates </div></div></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The preparation of financial statements in conformity with GAAP requires the Company&#8217;s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. </div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Document Type
DocumentType
10-Q
dei Amendment Flag
AmendmentFlag
false
dei Document Period End Date
DocumentPeriodEndDate
2019-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Trading Symbol
TradingSymbol
GSAH
dei Entity Registrant Name
EntityRegistrantName
GS Acquisition Holdings Corp
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Central Index Key
EntityCentralIndexKey
0001674101
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Shell Company
EntityShellCompany
true
dei Security12b Title
Security12bTitle
Common stock
dei Security Exchange Name
SecurityExchangeName
NYSE

Files In Submission

Name View Source Status
0001193125-19-284707-index-headers.html Edgar Link pending
0001193125-19-284707-index.html Edgar Link pending
0001193125-19-284707.txt Edgar Link pending
0001193125-19-284707-xbrl.zip Edgar Link pending
d810509d10q.htm Edgar Link pending
d810509dex311.htm Edgar Link pending
d810509dex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gsah-20191031.xml Edgar Link completed
gsah-20191031.xsd Edgar Link pending
gsah-20191031_cal.xml Edgar Link unprocessable
gsah-20191031_def.xml Edgar Link unprocessable
gsah-20191031_lab.xml Edgar Link unprocessable
gsah-20191031_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending